Skip to main content

Clifford Chance

Clifford Chance

News and awards

Clifford Chance advises Gilde Healthcare on the financing of its acquisition of Sanquin Reagents

2 November 2022

Clifford Chance advises Gilde Healthcare on the financing of its acquisition of Sanquin Reagents

International law firm Clifford Chance has advised specialised healthcare investor Gilde Healthcare on the financing provided by LGT Capital Partners of the acquisition by Gilde Healthcare of Sanquin Reagents. Read more about it here.

The Clifford Chance team was led by Boudewijn Vermeer and further consisted of Daniela Chilkevitsh, Inge de Bruin and Robin Houtveen.